Evidence map›Paper›PMID 36109183›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Development of a Lensless Radiomicroscope for Cellular-Resolution Radionuclide Imaging.

Justin S Klein, Tae Jin Kim, Guillem Pratx

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Justin S KleinDepartment of Radiation Oncology, Stanford University, Stanford, California.
Tae Jin KimDepartment of Radiation Oncology, Stanford University, Stanford, California.
Guillem PratxDepartment of Radiation Oncology, Stanford University, Stanford, California pratx@stanford.edu.
Stanford University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Stanford Molecular Imaging Scholars (SMIS) ProgramT32CA118681 · NCI · STANFORD UNIVERSITY · PI CRAIG S LEVIN · 2016 to 2026
$4.3M
NCI NIH HHS P30 CA124435NCI NIH HHS T32 CA118681
6 · The paper itself

Abstract

The action of radiopharmaceuticals takes place at the level of cells. However, existing radionuclide assays can only measure uptake in bulk or in small populations of single cells. This potentially hinders the development of effective radiopharmaceuticals for disease detection, staging, and treatment.

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsPositron-Emission TomographyRadioisotopesRadionuclide ImagingFluorodeoxyglucose F18RadioisotopesRadiopharmaceuticals18F-FDGCMOS detectorin vitro assaysradionuclide imaging

Identifiers

PMID36109183
PMCPMC10071797
OpenAlexW4296039640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.